Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The race for clinical trials on Omicron-based COVID-19 vaccine candidates: Updates from global databases
Sandro G. Viveiros-Rosa, Cristina DS. Mendes, Galo Guillermo Farfán-Cano, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e88-e88
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 200
Effects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 43
Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: A systematic review and meta‐analysis
Arto Yuwono Soeroto, Theo Audi Yanto, Andree Kurniawan, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 33
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study
Vishal Patel, Marcus J. Yarwood, Bethany Levick, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1323-1334
Open Access | Times Cited: 6
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE
Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, et al.
Advances in Therapy (2025)
Open Access
A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
Fallah Hashemi, Lori Hoepner, Farahnaz Soleimani Hamidinejad, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 28, pp. 72368-72388
Open Access | Times Cited: 15
COVID-19 pandemic sheds a new research spotlight on antiviral potential of essential oils – A bibliometric study
Binawati Ginting, Williams Chiari, Teuku Fais Duta, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17703-e17703
Open Access | Times Cited: 13
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
Benchen Rao, Daming Wang, Mengzhao Yang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose COVID-19 during the omicron epidemic: a nationwide surveillance study
Hsin Chi, Nan‐Chang Chiu, Chung-Chu Chen, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 11
Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
Ranjan K. Mohapatra, Snehasish Mishra, Venkataramana Kandi, et al.
Health Science Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 9
Exploring the relationship between SARS‐CoV‐2 variants, illness severity at presentation, in‐hospital mortality and COVID‐19 vaccination in a low middle‐income country: A retrospective cross‐sectional study
Muhammad Zain Mushtaq, Nosheen Nasir, Syed Faisal Mahmood, et al.
Health Science Reports (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 9
A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines
Stephan Gehring, Frank Kowalzik, Omar Okasha, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0294025-e0294025
Open Access | Times Cited: 2
The potential role of perceived neighborhood social cohesion on COVID-19 vaccination uptake among individuals aged 50 and older: Results from the Korean Community Health Survey
Younhee Kim, Min Kyung Lim
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312309-e0312309
Open Access | Times Cited: 2
Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain
Fabiana Ganem, Cinta Folch, Andreu Colom‐Cadena, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282871-e0282871
Open Access | Times Cited: 6
Fungal–Bacterial Co-Infections and Super-Infections among Hospitalized COVID-19 Patients: A Systematic Review
Farkad Bantun
Journal of Fungi (2023) Vol. 9, Iss. 6, pp. 598-598
Open Access | Times Cited: 5
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Characteristic profiles of patients with diabetes mellitus and COVID-19 during the second epidemic wave in East Java, Indonesia: a retrospective study
Batari Retno Minanti, Soebagijo Adi Soelistijo, Agung Pranoto
Bali Medical Journal (2023) Vol. 12, Iss. 1, pp. 1120-1126
Open Access | Times Cited: 4
Trust in federal COVID-19 vaccine oversight and parents’ willingness to vaccinate their children against COVID-19: a cross-sectional study
Hyunmin Yu, José A. Bauermeister, Ufuoma Oyiborhoro, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia
Harapan Harapan, Malik Sallam, Raisha Fathima, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 6, pp. 1017-1032
Open Access | Times Cited: 7
The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
Xiru Zhang, Zhi-Ju Li, Qi Fu, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
COVID-19 Vaccination and Clinical Outcomes at a Secondary Referral Hospital During the Delta Variant-dominant Period in West Sumatra, Indonesia
Didan Ariadapa Rahadi, Elfira Yusri, Syandrez Prima Putra, et al.
Journal of Preventive Medicine and Public Health (2023) Vol. 56, Iss. 3, pp. 221-230
Open Access | Times Cited: 2
A novel fast hybrid capture sequencing method for high-efficiency common human coronavirus whole-genome acquisition
Zixinrong Meng, Shuo Wang, Liping Yu, et al.
mSystems (2024) Vol. 9, Iss. 5
Open Access
Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database
Rita Karam, Katia Iskandar, Myriam Watfa, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
Comparing COVID-19 booster vaccine acceptance in the United Kingdom, Germany, Austria, and Jordan: The role of protection motivation theory, conspiracy beliefs, social media use and religiosity
Judith Eberhardt, Walid Al‐Qerem, Jonathan Ling
Vaccine (2024) Vol. 42, Iss. 26, pp. 126474-126474
Open Access
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
Page 1 - Next Page

Scroll to top